日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib

接受阿法替尼治疗的 EGFR 突变型非小细胞肺癌患者的基线炎症参数和炎症参数变化

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15338
Chang, Zi-Ting; Hsu, Ping-Chih; Ko, How-Wen; Chang, John Wen-Cheng; Wu, Chen-Te; Huang, Chen-Yang; Chang, Ching-Fu; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta; Wu, Chiao-En
肺癌
肿瘤
炎症
肿瘤免疫
炎症/感染
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study

S-1单药治疗非小细胞肺癌的真实世界疗效和安全性：一项多中心回顾性队列研究的启示

期刊:Clinical Medicine Insights-Oncology
影响因子:1.9
doi:10.1177/11795549251348367
Tsai, I-Lin; Lin, Chien-Yu; Su, Po-Lan; Lin, Chien-Chung; Chang, John Wen-Cheng; Huang, Chen-Yang; Fang, Yueh-Fu; Chang, Ching-Fu; Kuo, Chih-Hsi Scott; Hsu, Ping-Chih; Yang, Cheng-Ta; Wu, Chiao-En
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

在 II 期 LUMINOSITY 试验中，Telisotuzumab Vedotin 单药治疗既往接受过治疗的 c-Met 蛋白过表达的晚期非鳞状 EGFR 野生型非小细胞肺癌患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00720
Camidge, D Ross; Bar, Jair; Horinouchi, Hidehito; Goldman, Jonathan; Moiseenko, Fedor; Filippova, Elena; Cicin, Irfan; Ciuleanu, Tudor; Daaboul, Nathalie; Liu, Chunling; Bradbury, Penelope; Moskovitz, Mor; Katgi, Nuran; Tomasini, Pascale; Zer, Alona; Girard, Nicolas; Cuppens, Kristof; Han, Ji-Youn; Wu, Shang-Yin; Baijal, Shobhit; Mansfield, Aaron S; Kuo, Chih-Hsi; Nishino, Kazumi; Lee, Se-Hoon; Planchard, David; Baik, Christina; Li, Martha; Ansell, Peter; Xia, Summer; Bolotin, Ellen; Looman, Jim; Ratajczak, Christine; Lu, Shun
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

EGFR TKI治疗的晚期非小细胞肺癌中肿瘤和血浆T790M突变的差异性预后价值

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231222604
Tung, Pi-Hung; Chiu, Tzu-Hsuan; Huang, Allen Chung-Cheng; Ju, Jia-Shiuan; Huang, Chi-Hsien; Wang, Chin-Chou; Ko, How-Wen; Chung, Fu-Tsai; Hsu, Ping-Chih; Fang, Yueh-Fu; Guo, Yi-Ke; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective study

阿法替尼、吉非替尼和厄洛替尼治疗既往未接受过治疗的表皮生长因子受体突变晚期非小细胞肺癌老年患者的有效性和安全性：一项多中心回顾性研究

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.205395
Hung, Ling-Jen; Hsu, Ping-Chih; Yang, Cheng-Ta; Kuo, Chih-Hsi Scott; Chang, John Wen-Cheng; Huang, Chen-Yang; Chang, Ching-Fu; Wu, Chiao-En
细胞生物学
肿瘤
肿瘤免疫
信号转导
肺癌
发表日期：2024
文献求助 收藏

Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma

哮喘患者活化嗜酸性粒细胞mRNA表达与空气污染物暴露的相关性

期刊:Immunity Inflammation and Disease
影响因子:2.7
doi:10.1002/iid3.70065
Lin, Ting-Yu; Chang, Po-Jui; Lo, Chun-Yu; Chuang, Hsiao-Chi; Lee, Chung-Shu; Chang, Chih-Hao; Yu, Chih-Teng; Hsieh, Meng-Heng; Liu, Chien-Ying; Kuo, Chih-Hsi Scott; Lin, Shu-Min
细胞生物学
哮喘
粒细胞
发表日期：2024
文献求助 收藏

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

曲妥珠单抗德鲁替康治疗HER2突变型转移性非小细胞肺癌患者：随机II期DESTINY-Lung02试验的主要结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01361
Goto, Koichi; Goto, Yasushi; Kubo, Toshio; Ninomiya, Kiichiro; Kim, Sang-We; Planchard, David; Ahn, Myung-Ju; Smit, Egbert F; de Langen, Adrianus Johannes; Pérol, Maurice; Pons-Tostivint, Elvire; Novello, Silvia; Hayashi, Hidetoshi; Shimizu, Junichi; Kim, Dong-Wan; Kuo, Chih-Hsi; Yang, James Chih-Hsin; Pereira, Kaline; Cheng, Fu-Chih; Taguchi, Ayumi; Cheng, Yingkai; Feng, Wenqin; Tsuchihashi, Zenta; Jänne, Pasi A
肺癌
肿瘤
肿瘤免疫
HER2
细胞生物学
发表日期：2023
文献求助 收藏

Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers

奥希替尼和塞帕替尼在EGFR突变和RET融合阳性肺癌多中心前瞻性治疗队列中的疗效、安全性和耐药性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2189
Rotow, Julia; Patel, Jyoti D; Hanley, Matthew P; Yu, Helena; Awad, Mark; Goldman, Jonathan W; Nechushtan, Hovav; Scheffler, Matthias; Kuo, Chih-Hsi S; Rajappa, Senthil; Harada, Guilherme; Clifford, Sarah; Santucci, Alison; Silva, Laura; Tupper, Rebecca; Oxnard, Geoffrey R; Kherani, Jennifer; Drilon, Alexander
肺癌
肿瘤
RET
肿瘤免疫
EGF
EGFR
发表日期：2023
文献求助 收藏

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

脑转移、EGFR突变亚型以及EGFR-TKI的研发进展共同影响EGFR突变型非小细胞肺癌患者的治疗结局。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-45815-8
Ju, Jia-Shiuan; Huang, Allen Chung-Cheng; Tung, Pi-Hung; Huang, Chi-Hsien; Chiu, Tzu-Hsuan; Wang, Chin-Chou; Ko, How-Wen; Chung, Fu-Tsai; Hsu, Ping-Chih; Fang, Yueh-Fu; Guo, Yi-Ke; Kuo, Chih-Hsi Scott; Yang, Cheng-Ta
EGFR
细胞生物学
肿瘤
神经科学
EGF
肿瘤免疫
肺癌
发表日期：2023
文献求助 收藏

Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan

表皮生长因子受体酪氨酸激酶抑制剂治疗携带罕见EGFR突变的非小细胞肺癌：来自台湾的真实世界数据

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14537
Chang, John Wen-Cheng; Huang, Chen-Yang; Fang, Yueh-Fu; Chang, Ching-Fu; Yang, Cheng-Ta; Kuo, Chih-Hsi Scott; Hsu, Ping-Chih; Wu, Chiao-En
肺癌
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
细胞生物学
发表日期：2023
文献求助 收藏